Published January 10, 2018
| Version v1
Conference paper
Open
Assessing the safety of Rosiglitazone for the treatment of type II diabetes
Authors/Creators
- 1. London School of Economics and Political Science
Description
A Bayesian paradigm for making drug approval decisions. Case study in the treatment of Diabetes (Type 2).
Notes
Code and data available at github.com/stan-dev/stancon_talks